{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:23:20Z","timestamp":1771071800783,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":103,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["274728"],"award-info":[{"award-number":["274728"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["316796"],"award-info":[{"award-number":["316796"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Foundation of Finland","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100011797","name":"Turku University Hospital","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1074\/jbc.ra119.010925","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T18:45:13Z","timestamp":1592592313000},"page":"11559-11571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration"],"prefix":"10.1016","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5204-8899","authenticated-orcid":false,"given":"Veera K.","family":"Ojala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Knittle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peppi","family":"Kirjalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-5175","authenticated-orcid":false,"given":"Johannes A.M.","family":"Merilahti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarit","family":"Kortesoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-1347","authenticated-orcid":false,"given":"Denis","family":"Tvorogov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-4427","authenticated-orcid":false,"given":"Katri","family":"Vaparanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Kast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-8963","authenticated-orcid":false,"given":"Arto T.","family":"Pulliainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari J.","family":"Kurppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-0827","authenticated-orcid":false,"given":"Klaus","family":"Elenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.010925_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: at last, cancer therapy meets systems biology","volume":"12","author":"Yarden","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.RA119.010925_bib2","doi-asserted-by":"crossref","first-page":"26761","DOI":"10.1074\/jbc.272.42.26761","article-title":"A novel juxtamembrane domain isoform of HER4\/ErbB4: isoform-specific tissue distribution and differential processing in response to phorbol ester","volume":"272","author":"Elenius","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib3","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1074\/jbc.275.14.10379","article-title":"Tumor necrosis factor-converting enzyme is required for cleavage of erbB4\/HER4","volume":"275","author":"Rio","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib4","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1126\/science.1065412","article-title":"\u03b3-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase","volume":"294","author":"Ni","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010925_bib5","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1038\/sj.onc.1202612","article-title":"Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase","volume":"18","author":"Elenius","year":"1999","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA119.010925_bib6","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0708333105","article-title":"Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms","volume":"105","author":"Sundvall","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/jbc.RA119.010925_bib7","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1096\/fj.06-7925com","article-title":"The E3 ligase Aip4\/Itch ubiquitinates and targets ErbB-4 for degradation","volume":"21","author":"Omerovic","year":"2007","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA119.010925_bib8","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.4161\/cc.10.16.17194","article-title":"Function of ERBB4 is determined by alternative splicing","volume":"10","author":"Veikkolainen","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.RA119.010925_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/fon.09.144","article-title":"Potential of ErbB4 antibodies for cancer therapy","volume":"6","author":"Hollm\u00e9n","year":"2010","journal-title":"Future Oncol"},{"key":"10.1074\/jbc.RA119.010925_bib10","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1074\/jbc.275.12.8641","article-title":"A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis","volume":"275","author":"Kainulainen","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1091\/mbc.e05-05-0402","article-title":"Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth","volume":"17","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.RA119.010925_bib12","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/sj.onc.1210501","article-title":"Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains","volume":"26","author":"Sundvall","year":"2007","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA119.010925_bib13","doi-asserted-by":"crossref","first-page":"23216","DOI":"10.1074\/jbc.M111.335927","article-title":"Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein","volume":"287","author":"Sundvall","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib14","doi-asserted-by":"crossref","first-page":"25373","DOI":"10.1074\/jbc.M603998200","article-title":"ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression","volume":"281","author":"Linggi","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41388-018-0465-z","article-title":"\u03b3-Secretase-dependent signaling of receptor tyrosine kinases","volume":"38","author":"Merilahti","year":"2018","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA119.010925_bib16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1541-7786.MCR-10-0042","article-title":"Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways","volume":"8","author":"Gilmore-Hebert","year":"2010","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/jbc.RA119.010925_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/21541248.2014.973757","article-title":"Vav family exchange factors: an integrated regulatory and functional view","volume":"5","author":"Bustelo","year":"2014","journal-title":"Small GTPases"},{"key":"10.1074\/jbc.RA119.010925_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/BST20170531","article-title":"RHO GTPases in cancer: known facts, open questions, and therapeutic challenges","volume":"46","author":"Bustelo","year":"2018","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.RA119.010925_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1073\/pnas.97.1.179","article-title":"Analysis of receptor signaling pathways by mass spectrometry: identification of Vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors","volume":"97","author":"Pandey","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/jbc.RA119.010925_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/msb4100012","article-title":"Phosphotyrosine interactome of the ErbB-receptor kinase family","volume":"1","author":"Schulze","year":"2005","journal-title":"Mol. Syst. Biol"},{"key":"10.1074\/jbc.RA119.010925_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.010925_bib22","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1074\/jbc.M207555200","article-title":"Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac","volume":"278","author":"Tam\u00e1s","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib23","doi-asserted-by":"crossref","first-page":"15289","DOI":"10.1074\/jbc.M500275200","article-title":"Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76","volume":"280","author":"Charvet","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.chembiol.2008.07.006","article-title":"System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties","volume":"15","author":"Kaushansky","year":"2008","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.RA119.010925_bib25","doi-asserted-by":"crossref","first-page":"e44471","DOI":"10.1371\/journal.pone.0044471","article-title":"Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors","volume":"7","author":"Hause","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA119.010925_bib26","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.1128\/MCB.19.11.7870","article-title":"Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins","volume":"19","author":"Movilla","year":"1999","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.RA119.010925_bib27","doi-asserted-by":"crossref","first-page":"20246","DOI":"10.1074\/jbc.271.34.20246","article-title":"Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)","volume":"271","author":"Amano","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.271.5249.645","article-title":"Protein kinase N (PKN) and PKN-related protein Rhophilin as targets of small GTPase Rho","volume":"271","author":"Watanabe","year":"1996","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010925_bib29","doi-asserted-by":"crossref","first-page":"ra116","DOI":"10.1126\/scisignal.2005770","article-title":"Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration","volume":"7","author":"Haskins","year":"2014","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA119.010925_bib30","doi-asserted-by":"crossref","first-page":"ra78","DOI":"10.1126\/scisignal.2005157","article-title":"The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility","volume":"7","author":"Kiuchi","year":"2014","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA119.010925_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/1947601911431080","article-title":"ErbB2 is necessary for ErbB4 ligands to stimulate oncogenic activities in models of human breast cancer","volume":"2","author":"Mill","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1074\/jbc.RA119.010925_bib32","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/gb-2008-9-9-r139","article-title":"Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues","volume":"9","author":"Kilpinen","year":"2008","journal-title":"Genome Biol"},{"key":"10.1074\/jbc.RA119.010925_bib33","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1128\/MCB.20.17.6364-6373.2000","article-title":"Vav family proteins couple to diverse cell surface receptors","volume":"20","author":"Moores","year":"2000","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.RA119.010925_bib34","doi-asserted-by":"crossref","first-page":"ra71","DOI":"10.1126\/scisignal.2002962","article-title":"The Rho exchange factors Vav2 and Vav3 control a lung metastasis-specific transcriptional program in breast cancer cells","volume":"5","author":"Citterio","year":"2012","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA119.010925_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10911-008-9079-3","article-title":"Role of ErbB4 in breast cancer","volume":"13","author":"Sundvall","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1074\/jbc.RA119.010925_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-8-158","article-title":"Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer","volume":"8","author":"Lee","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.RA119.010925_bib37","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/bcr3664","article-title":"VAV3 mediates resistance to breast cancer endocrine therapy","volume":"16","author":"Aguilar","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1074\/jbc.RA119.010925_bib38","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3892\/ol.2015.3004","article-title":"Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients","volume":"9","author":"Chen","year":"2015","journal-title":"Oncol. Lett"},{"key":"10.1074\/jbc.RA119.010925_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.112.197756","article-title":"Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker","volume":"343","author":"Solca","year":"2012","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.RA119.010925_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00210-014-0967-3","article-title":"A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer","volume":"387","author":"Modjtahedi","year":"2014","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol"},{"key":"10.1074\/jbc.RA119.010925_bib41","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1074\/jbc.M805438200","article-title":"Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer","volume":"284","author":"Tvorogov","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib42","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.010925_bib43","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","article-title":"Single-pot, solid-phase-enhanced sample preparation for proteomics experiments","volume":"14","author":"Hughes","year":"2019","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.RA119.010925_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nmeth.4607","article-title":"Picky: a simple online PRM and SRM method designer for targeted proteomics","volume":"15","author":"Zauber","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.RA119.010925_bib46","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1074\/jbc.RA119.010925_bib47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41592-019-0426-7","article-title":"Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning","volume":"16","author":"Gessulat","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.RA119.010925_bib48","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.010925_bib49","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1074\/jbc.271.7.3884","article-title":"Transformation of NIH 3T3 Cells by HER3 or HER4 receptors requires the presence of HER1 or HER2","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.010925_bib50","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.RA119.010925_bib51","first-page":"5346","article-title":"Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients","volume":"9","author":"Junttila","year":"2003","journal-title":"Clin. Cancer Res"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817484584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817484584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.010925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T15:11:56Z","timestamp":1640963516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817484584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":51,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0021925817484584"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.010925","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.010925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Ojala et al.","name":"copyright","label":"Copyright"}]}}